药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Sultopride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sultopride.
Potassium cation
Clothiapine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clothiapine.
Potassium cation
Proxibarbal
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Proxibarbal.
Potassium cation
Quinupramine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quinupramine.
Potassium cation
Propanidid
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Propanidid.
Potassium cation
Alaproclate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alaproclate.
Potassium cation
Dibenzepin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dibenzepin.
Potassium cation
Apronalide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Apronalide.
Potassium cation
Medifoxamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Medifoxamine.
Potassium cation
Butaperazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butaperazine.
Potassium cation
Alphaprodine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alphaprodine.
Potassium cation
Amitriptylinoxide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amitriptylinoxide.
Potassium cation
Valnoctamide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Valnoctamide.
Potassium cation
Nefiracetam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nefiracetam.
Potassium cation
Tiapride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tiapride.
Potassium cation
Hypericin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hypericin.
Potassium cation
Neosaxitoxin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Neosaxitoxin.
Potassium cation
Prothipendyl
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Prothipendyl.
Potassium cation
Pivagabine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pivagabine.
Potassium cation
Opipramol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Opipramol.